Last reviewed · How we verify
Dilaudid IV Scheduled
At a glance
| Generic name | Dilaudid IV Scheduled |
|---|---|
| Also known as | hydromorphone |
| Sponsor | TriHealth Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dilaudid IV Scheduled CI brief — competitive landscape report
- Dilaudid IV Scheduled updates RSS · CI watch RSS
- TriHealth Inc. portfolio CI